Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Robert Pecha"'
Autor:
Faris Haddadin, Monil Majmundar, Robert Pecha, Claire Scott, Marilyne Daher, Soufian AlMahameed, Christopher V. DeSimone, Yong-Mei Cha, Siva K. Mulpuru, Kenneth A. Ellenbogen, Mohammad Saeed, Mihail G. Chelu, Abhishek J. Deshmukh
Publikováno v:
Heart Rhythm. 19:S172-S173
Autor:
Naoki Misumida, Elliott Goodwin, Susan S. Smyth, Robert Pecha, Adrian W. Messerli, Dustin Hillerson, Ahmed Abdel-Latif, Claude S. Elayi, Karam Ayoub, Ayman Elbadawi, Gbolahan O. Ogunbayo
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 56:104-107
Introduction Malignancy is a common cause of morbidity and mortality in the United States and around the world and the second leading cause of death in the United States. There is little data on the impact of metastatic cancer on the risk of hemorrha
Autor:
Ayman Elbadawi, Adrian W. Messerli, Robert Pecha, Dustin Hillerson, Ahmed Abdel-Latif, Gbolahan O. Ogunbayo, Susan S. Smyth, Claude S. Elayi, Naoki Misumida
Publikováno v:
The American Journal of Cardiology. 123:212-217
Hemorrhagic stroke (HS) is a feared complication of Fibrinolytic therapy (FT). Risk assessment scores may help in risk stratification to reduce this complication. Patients (admissions) ≥18 years with a primary diagnosis of ST-elevation myocardial i
Autor:
Claude S. Elayi, Mohamed Omar, Ayman Elbadawi, Robert Pecha, Ahmed Abdel-Latif, Rachel P. Goodwin, Adrian W. Messerli, Gbolahan O. Ogunbayo, Dustin Hillerson, Elliott Goodwin
Publikováno v:
The American Journal of Cardiology. 124:1650-1652
Autor:
Naoki Misumida, Gbolahan O. Ogunbayo, Adrian W. Messerli, Ahmed Abdel-Latif, Karam Ayoub, Robert Pecha, Dustin Hillerson, Susan S. Smyth, Claude S. Elayi
Publikováno v:
Circulation. 138
Introduction: Pulmonary embolism in the setting of cancer portends a poor prognosis. There is limited data on the use and outcomes of fibrinolytic therapy (FT) in this subgroup of patients. This study describes temporal trends and outcomes of the use
Autor:
Gbolahan O, Ogunbayo, Robert, Pecha, Naoki, Misumida, Dustin, Hillerson, Ayman, Elbadawi, Ahmed, Abdel-Latif, Claude S, Elayi, Adrian W, Messerli, Susan S, Smyth
Publikováno v:
The American journal of cardiology. 123(2)
Hemorrhagic stroke (HS) is a feared complication of Fibrinolytic therapy (FT). Risk assessment scores may help in risk stratification to reduce this complication. Patients (admissions) ≥18 years with a primary diagnosis of ST-elevation myocardial i
Autor:
Ahmed Abdel-Latif, Khaled M. Ziada, Gbolahan O. Ogunbayo, Naoki Misumida, John C. Gurley, Adrian W. Messerli, Ayman Elbadawi, Robert Pecha, Elliott Goodwin, Claude S. Elayi
Publikováno v:
The American Journal of Cardiology. 124:321-322
Autor:
Naoki Misumida, Elliott Goodwin, Susan S. Smyth, Andrew Leventhal, Gbolahan O. Ogunbayo, Adrian W. Messerli, Samy-Claude Elayi, Ayman Elbadawi, Ahmed Abdel-Latif, Robert Pecha
Publikováno v:
Journal of the American College of Cardiology. 73:595
Atrial septal defect is a common congenital heart disease. We designed a propensity-match analysis to describe the outcomes of acute PE in patients with ASD. Our primary outcome of interest was embolic cerebrovascular events (stroke/TIA). Using the N
Autor:
Samy-Claude Elayi, Robert Pecha, Ahmed Abdel-Latif, Karam Ayoub, Naoki Misumida, Susan S. Smyth, Ayman Elbadawi, Elliott Goodwin, Adrian W. Messerli, Gbolahan O. Ogunbayo
Publikováno v:
Journal of the American College of Cardiology. 73:1906
Autor:
Robert Pecha, Gbolahan O. Ogunbayo, Adrian W. Messerli, Ayman Elbadawi, Ahmed Abdel-Latif, Karam Ayoub, Dustin Hillerson, Susan S. Smyth, Naoki Misumida
Publikováno v:
Journal of the American College of Cardiology. 72:B345
Fibrinolytic therapy (FT) is recommended as an alternative reperfusion strategy in patients with ST elevation myocardial infarction (STEMI), when percutaneous coronary intervention (PCI) is not readily accessible. This study describes trends and outc